YOKNEAM, Israel, March 2,
2023 /PRNewswire/ -- InMode Ltd. (Nasdaq:
INMD), a leading global provider of innovative medical
technologies, today announced that Yair
Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer, will
present in-person at the Barclays Global Health Conference in
Miami on March 15, 2023.
The fireside chat, moderated by Matt
Miksic, equity research analyst, is scheduled for
9:30 am Eastern Time on Wednesday,
March 15 and will be webcast from InMode's Investor Relations
website at https://inmodemd.com/investors/. InMode will also hold
one-on-one investor meetings in person that same day. To schedule a
meeting, please contact your Barclays representative.
For more information about the event, visit InMode's investor
relations site here.
About InMode
InMode is a leading global provider of innovative medical
technologies. InMode develops, manufactures, and markets devices
harnessing novel radiofrequency ("RF") technology. InMode strives
to enable new emerging surgical procedures as well as improve
existing treatments. InMode has leveraged its medically accepted
minimally invasive RF technologies to offer a comprehensive line of
products across several categories for plastic surgery, gynecology,
dermatology, otolaryngology, and ophthalmology. For more
information about InMode, please visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654
View original
content:https://www.prnewswire.com/news-releases/inmode-to-present-in-person-at-the-barclays-global-health-conference-301758856.html
SOURCE InMode LTD